Latest round: Series A. Liu Dong is the CEO and chief scientific officer of Kind Pharmaceuticals, a clinical-stage biopharmaceutical company.
Liu Dong is the CEO and chief scientific officer of Kind Pharmaceuticals, a clinical-stage biopharmaceutical company. The company focuses on developing medicines for hematological diseases and cancers by advancing its lead program AND017 through FDA regulatory milestones and clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library